PARP inhibition in cancer therapy

22 ta ish

Lytic and sublytic effects of gossypol on red blood cells and thymocytes
Nargiza M. Chorieva, Diyor D. Fayziev, Nargiza A. Tsiferova +7
MaqolaPARP inhibition in cancer therapyClinical and Experimental Pharmacology and Physiology20208 iqtibos
ABI
Mathematical modeling of regulatory mechanisms of cardiological pathologies in the tumor process
Mahruy Saidalieva, Margarita Gildieva, Anvar Abduvaliev +1
MaqolaChemotherapy-induced cardiotoxicity and mitigation2019 International Conference on Information Science and Communications Technologies (ICISCT)20192 iqtibos
ABI
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone
Muzaffar Kayumov, Jia Li, Azizbek Pardaev +9
MaqolaPARP inhibition in cancer therapyEuropean Journal of Medicinal Chemistry20222 iqtibos
ABI
Down-regulation of poly (ADP-ribose) polymerase 1 leads to change of hydroquinone cytotoxicity in TK6 cells.
Yan Sha, Wei Zhou, Zhenyu Yang +4
MaqolaPARP inhibition in cancer therapyPubMed20150 iqtibos
ABI
The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan
Abdulla Abdikhakimov, Mukaddas Tukhtaboeva, Bakhtiyar Adilov +1
MaqolaBRCA gene mutations in cancerCentral Asian Journal of Global Health20160 iqtibos
ABI
BEVACIZUMAB AS MAINTENANCE TREATMENT IN PATIENTS WITH OVARIAN CANCER
O. Akhmedov
MaqolaOvarian cancer diagnosis and treatmentEurasianUnionofScientists20190 iqtibos
ABI
The role of p53 gene suppressor and Bcl-2 oncoprotein in germ cell ovarian tumor prognosis determination among child and adolescent patients
Anvar T. Shukullaev
MaqolaTesticular diseases and treatmentsPediatric Hematology Oncology Journal20200 iqtibos
ABI
Frequencies of the C1236T, G2677T/A, and C3435T Polymorphisms of the MDR1 Gene and their Haplotypes in Uzbekistan
S. B. Nurmatova, Abrorjon Abdurakhimov, O. S. Charishnikova +2
MaqolaDrug Transport and Resistance MechanismsAmerican journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology20220 iqtibos
ABI
TARGETED THERAPY IN THE PALLIATIVE TREATMENT OF PLATINUM-RESISTANT RECURRENT OVARIAN CANCER COMPLICATED BY ASCITES
Sh.Sh. Shakhanova, J.A. Abdurakhmonov, N.M. Rakhimov
MaqolaOvarian cancer diagnosis and treatmentThe American Journal of Medical Sciences and Pharmaceutical Research20230 iqtibos
ABI
Cardiac Injury Following Chemo/Radiation Therapy: An Updated Reviewon Mechanisms and Therapeutic Approaches
Krishanveer Singh, Ameer A. Alameri, Ammar Ali Hamza +7
Sharh maqolaChemotherapy-induced cardiotoxicity and mitigationCurrent Radiopharmaceuticals20230 iqtibos
ABI
Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer
Altin Goxharaj, Nizom Suyunov, E.L. Nikolaev +2
MaqolaCancer Genomics and DiagnosticsJournal of cancer research updates20240 iqtibos
ABI
The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.
Kamila Izrailbekova, Sergey Kamishov, Sunnatilla Saydullaev +4
MaqolaPARP inhibition in cancer therapyJournal of Clinical Oncology20240 iqtibos
ABI
Structure-driven design and precision translation of functionally diverse isatin-based CDK2 inhibitors: Advances in SAR, polypharmacology, and biomarker-guided cancer therapy
Safia Obaidur Rab, A. Al-Shahrani, Lalji Baldaniya +9
MaqolaCancer-related Molecular PathwaysJournal of Molecular Structure20250 iqtibos
ABI
A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors
Saade Abdalkareem Jasim, Jitendra Gupta, Subasini Uthirapathy +7
Sharh maqolaCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
ABI
Diagnostic Performance of ROMA and Biomarkers in Ovarian Cancer: A Systematic Review of Sensitivity, Specificity, and Menopausal Influence
Dilfuza Botirjonovna Mirzaeva, Dilshod Tolibov, Kalash Dwivedi
MaqolaOvarian cancer diagnosis and treatmentIndian Journal of Medical and Paediatric Oncology20260 iqtibos
ABI
Abstract 2510: Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations
Zilola Avazovna Olimova, Gowhar Shafi, D. Farrukh +10
MaqolaCancer Genomics and DiagnosticsCancer Research20260 iqtibos
ABI
OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION
Abror Abduxoliq ugli Rajabbayev
MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION
Abror Abduxoliq ugli Rajabbayev
MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION
Abror Abduxoliq ugli Rajabbayev
MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
OVARIAN CANCER: MORPHOLOGY, CLINICAL FEATURES AND MODERN APPROACHES TO SCREENING AND PREVENTION
Abror Abduxoliq ugli Rajabbayev
MaqolaOvarian cancer diagnosis and treatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
Resveratrol-loaded liposomes regulate mitochondrial oxidative stress through the HIGD1A/NF-κB/SOD2 signaling pathway to improve chemotherapy-induced ovarian injury
Shuhong Yang, Chendi Zhang, Diyorakhon Nabieva +2
MaqolaSirtuins and Resveratrol in MedicineNanomedicine20260 iqtibos
ABI
Liposomes containing histidine overcome poly ADP-ribose polymerase inhibitor resistance
Jing Zhang (23775), Muhammad Tufail, Yun Deng +11
MaqolaPARP inhibition in cancer therapyDrug Resistance Updates20260 iqtibos
ABI